Aethlon Medical Inc. [NASDAQ: AEMD] stock went on an upward path that rose over 388.24% on Wednesday, amounting to a one-week price increase of more than 361.11%. The company report on June 8, 2021 that AEMD: First Ever In Vivo Removal of COVID Virus From Bloodstream of An Infected Patient.
By M. Marin.
Over the last 12 months, AEMD stock rose by 605.23%. The average equity rating for AEMD stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $136.17 million, with 12.09 million shares outstanding and 11.89 million shares in the current float. Compared to the average trading volume of 483.09K shares, AEMD stock reached a trading volume of 252427343 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Aethlon Medical Inc. [AEMD]:
The Average True Range (ATR) for Aethlon Medical Inc. is set at 0.89, with the Price to Sales ratio for AEMD stock in the period of the last 12 months amounting to 170.21. The Price to Book ratio for the last quarter was 11.24, with the Price to Cash per share for the same quarter was set at 0.96.
AEMD Stock Performance Analysis:
Aethlon Medical Inc. [AEMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 361.11. With this latest performance, AEMD shares gained by 550.00% in over the last four-week period, additionally plugging by 506.18% over the last 6 months – not to mention a rise of 605.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AEMD stock in for the last two-week period is set at 96.62, with the RSI for the last a single of trading hit 98.02, and the three-weeks RSI is set at 94.71 for Aethlon Medical Inc. [AEMD]. The present Moving Average for the last 50 days of trading for this stock 2.06, while it was recorded at 3.94 for the last single week of trading, and 1.95 for the last 200 days.
Insight into Aethlon Medical Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Aethlon Medical Inc. [AEMD] shares currently have an operating margin of -912.04. Aethlon Medical Inc.’s Net Margin is presently recorded at -980.33.
Return on Total Capital for AEMD is now -93.53, given the latest momentum, and Return on Invested Capital for the company is -107.33. Return on Equity for this stock declined to -107.72, with Return on Assets sitting at -87.85. When it comes to the capital structure of this company, Aethlon Medical Inc. [AEMD] has a Total Debt to Total Equity ratio set at 1.50. Additionally, AEMD Total Debt to Total Capital is recorded at 1.48, with Total Debt to Total Assets ending up at 1.36. Long-Term Debt to Equity for the company is recorded at 0.45, with the Long-Term Debt to Total Capital now at 0.45.
Reflecting on the efficiency of the workforce at the company, Aethlon Medical Inc. [AEMD] managed to generate an average of -$796,743 per employee. Receivables Turnover for the company is 6.29 with a Total Asset Turnover recorded at a value of 0.09.Aethlon Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.00 and a Current Ratio set at 10.00.
AEMD Stock EPS
With the latest financial reports released by the company, Aethlon Medical Inc. posted -0.28/share EPS, while the average EPS was predicted by analysts to be reported at -1.03/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 72.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AEMD.
Aethlon Medical Inc. [AEMD] Insider Position Details
There are presently around $8 million, or 8.40% of AEMD stock, in the hands of institutional investors. The top three institutional holders of AEMD stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 306,300, which is approximately New of the company’s market cap and around 1.30% of the total institutional ownership; VANGUARD GROUP INC, holding 171,182 shares of the stock with an approximate value of $1.85 million in AEMD stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.72 million in AEMD stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Aethlon Medical Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 13 institutional holders increased their position in Aethlon Medical Inc. [NASDAQ:AEMD] by around 401,640 shares. Additionally, 2 investors decreased positions by around 27,875 shares, while 9 investors held positions by with 274,974 shares. The mentioned changes placed institutional holdings at 704,489 shares, according to the latest SEC report filing. AEMD stock had 9 new institutional investments in for a total of 384,459 shares, while 2 institutional investors sold positions of 27,875 shares during the same period.